---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-001179"
form_type: "8-K"
ticker: "AVXL"
cik: "0001314052"
company_name: "ANAVEX LIFE SCIENCES CORP."
filed_at: "2026-09-02T21:06:24+00:00"
generated_at: "2026-09-02T21:08:05.197814+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anavex regains Nasdaq compliance after filing delinquent 10-Qs for Q2 and Q3 FY2026

## Summary
- Nasdaq confirmed compliance with Listing Rule 5250(c)(1) on September 2, 2026.
- Delinquency notice received May 20, 2026; compliance plan submitted July 20, 2026.
- Filed 10-Qs for periods ended March 31 and June 30, 2026 on August 28, 2026.
- Common stock continues trading on Nasdaq Global Select Market under ticker AVXL.
- Company cites advancing all three core CNS indications as ongoing strategy.

## SEC filing metadata
- accession: 0001731122-26-001179
- form_type: 8-K
- ticker: AVXL
- cik: 0001314052
- company_name: ANAVEX LIFE SCIENCES CORP.
- filed_at: 2026-09-02T21:06:24+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/0001731122-26-001179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/e7909_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-001179
- JSON: https://secwatch.observer/filing/0001731122-26-001179.json
- Plain text: https://secwatch.observer/filing/0001731122-26-001179.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.